Valuation dashboard for BNB Plus Corp. (BNBX) with P/E N/A, P/B 0.13, EV/EBITDA -0.04 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments.
Analysis Summary
Trailing-twelve-month margins: gross margin 43.5%, operating margin -12.1%, net margin -16.5%.
At the current price of $0.16, BNBX has negative trailing earnings (P/E not meaningful) and an ROE of -6.58%. Market capitalisation stands at $0M.
Balance sheet quality for BNBX: current ratio of 0.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.13 |
| EV / EBITDA | -0.04 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-56.71 |
| vs Current Price | -34891.2% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BNBX | BNB Plus Corp. | 0.13 | -6.6% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $0.16 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -657.80% |
| Return on Invested Capital | -708.18% |
| Return on Assets | -341.65% |
| Gross Margin | 43.49% |
| Operating Margin | -1209.55% |
| Net Margin | -1646.94% |
Related companies: BGMS · BNGO · CANF · ISPC · KZIA · NAOV · NDRA
Explore sector: Healthcare · Biotechnology
More sections of BNBX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks